Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
Journal of Clinical Medicine
|
September 8, 2019
Closing the Gap in Surveillance and Audit of Invasive Mold Diseases for Antifungal Stewardship Using Machine Learning
Diva Baggio, Trisha Peel, Anton Y Peleg, et al.
Hypertension (Dallas, Tex. : 1979)
|
July 21, 2023
Vascular Aging Is Accelerated in Hematological Cancer Survivors Who Undergo Allogeneic Stem Cell Transplant
Rachel E Climie, Hayley T Dillon, Yuki Horne-Okano, et al.
Haematologica
|
July 4, 2007
Blood transfusion requirements for patients undergoing chemotherapy for acute myeloid leukemia how much is enough?
Mark A Dawson, Sharon Avery, Zoe K McQuilten, et al.
Clinical & Translational Immunology
|
October 17, 2018
Contemporary analysis of functional immune recovery to opportunistic and vaccine-preventable infections after allogeneic haemopoietic stem cell transplantation
Harini D de Silva, Rosemary A Ffrench, Maya Korem, et al.
Blood
|
December 15, 2010
Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts
Sharon Avery, Weiji Shi, Marissa Lubin, et al.
American Journal of Hematology
|
August 29, 2015
Immunological markers for prognostication in cytogenetically normal acute myeloid leukemia
Victoria Y Ling, Denise Lee, Zoe Mcquilten, et al.
Blood Reviews
|
March 3, 2018
Standing up to the cardiometabolic consequences of hematological cancers
Erin J Howden, André La Gerche, Jane F Arthur, et al.
Leukemia & Lymphoma
|
February 18, 2014
Excellent outcomes for adolescents and adults with acute lymphoblastic leukemia and lymphoma without allogeneic stem cell transplant: the FRALLE-93 pediatric protocol
Jay Hocking, Anthony P Schwarer, Robin Gasiorowski, et al.
Leukemia & Lymphoma
|
July 21, 2012
Fludarabine, cytarabine, granulocyte-colony stimulating factor and amsacrine: an effective salvage therapy option for acute myeloid leukemia at first relapse
Chun Yew Fong, George Grigoriadis, Jay Hocking, et al.
Oncotarget
|
September 9, 2017
The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study
Peter Tan, Ing Soo Tiong, Shaun Fleming, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
Journal of Clinical Medicine
|
September 8, 2019
Closing the Gap in Surveillance and Audit of Invasive Mold Diseases for Antifungal Stewardship Using Machine Learning
Diva Baggio, Trisha Peel, Anton Y Peleg, et al.
Hypertension (Dallas, Tex. : 1979)
|
July 21, 2023
Vascular Aging Is Accelerated in Hematological Cancer Survivors Who Undergo Allogeneic Stem Cell Transplant
Rachel E Climie, Hayley T Dillon, Yuki Horne-Okano, et al.
Haematologica
|
July 4, 2007
Blood transfusion requirements for patients undergoing chemotherapy for acute myeloid leukemia how much is enough?
Mark A Dawson, Sharon Avery, Zoe K McQuilten, et al.
Clinical & Translational Immunology
|
October 17, 2018
Contemporary analysis of functional immune recovery to opportunistic and vaccine-preventable infections after allogeneic haemopoietic stem cell transplantation
Harini D de Silva, Rosemary A Ffrench, Maya Korem, et al.
Blood
|
December 15, 2010
Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts
Sharon Avery, Weiji Shi, Marissa Lubin, et al.
American Journal of Hematology
|
August 29, 2015
Immunological markers for prognostication in cytogenetically normal acute myeloid leukemia
Victoria Y Ling, Denise Lee, Zoe Mcquilten, et al.
Blood Reviews
|
March 3, 2018
Standing up to the cardiometabolic consequences of hematological cancers
Erin J Howden, André La Gerche, Jane F Arthur, et al.
Leukemia & Lymphoma
|
February 18, 2014
Excellent outcomes for adolescents and adults with acute lymphoblastic leukemia and lymphoma without allogeneic stem cell transplant: the FRALLE-93 pediatric protocol
Jay Hocking, Anthony P Schwarer, Robin Gasiorowski, et al.
Leukemia & Lymphoma
|
July 21, 2012
Fludarabine, cytarabine, granulocyte-colony stimulating factor and amsacrine: an effective salvage therapy option for acute myeloid leukemia at first relapse
Chun Yew Fong, George Grigoriadis, Jay Hocking, et al.
Oncotarget
|
September 9, 2017
The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study
Peter Tan, Ing Soo Tiong, Shaun Fleming, et al.
Page
of 5